AAAAAA
Results:
1-14
|
Results: 14
Authors:
Wagenknecht, B
Roth, W
Gulbins, E
Wolburg, H
Weller, M
Citation: B. Wagenknecht et al., C2-ceramide signaling in glioma cells: synergistic enhancement of CD95-mediated, caspase-dependent apoptosis, CELL DEAT D, 8(6), 2001, pp. 595-602
Authors:
Roth, W
Wagenknecht, B
Klumpp, A
Naumann, U
Hahne, M
Tschopp, J
Weller, M
Citation: W. Roth et al., APRIL, a new member of the tumor necrosis factor family, modulates death ligand-induced apoptosis, CELL DEAT D, 8(4), 2001, pp. 403-410
Authors:
Glaser, T
Wagenknecht, B
Weller, M
Citation: T. Glaser et al., Identification of p21 as a target of cycloheximide-mediated facilitation of CD95-mediated apoptosis in human malignant glioma cells, ONCOGENE, 20(35), 2001, pp. 4757-4767
Authors:
Rohn, TA
Wagenknecht, B
Roth, W
Naumann, U
Gulbins, E
Krammer, PH
Walczak, H
Weller, M
Citation: Ta. Rohn et al., CCNU-dependent potentiation of TRAIL/Apo2L-induced apoptosis in human glioma cells is p53-independent but may involve enhanced cytochrome c release, ONCOGENE, 20(31), 2001, pp. 4128-4137
Authors:
Leitlein, J
Aulwurm, S
Waltereit, R
Naumann, U
Wagenknecht, B
Garten, W
Weller, M
Platten, M
Citation: J. Leitlein et al., Processing of immunosuppressive pro-TGF-beta 1,2 by human glioblastoma cells involves cytoplasmic and secreted furin-like proteases, J IMMUNOL, 166(12), 2001, pp. 7238-7243
Authors:
Hermisson, M
Wagenknecht, B
Wolburg, H
Glaser, T
Dichgans, J
Weller, M
Citation: M. Hermisson et al., Sensitization to CD95 ligand-induced apoptosis in human glioma cells by hyperthermia involves enhanced cytochrome c release, ONCOGENE, 19(19), 2000, pp. 2338-2345
Authors:
Zipp, F
Wendling, U
Beyer, M
Grieger, U
Waiczies, S
Wagenknecht, B
Haas, J
Weller, M
Citation: F. Zipp et al., Dual effect of glucocorticoids on apoptosis of human autoreactive and foreign antigen-specific T cells, J NEUROIMM, 110(1-2), 2000, pp. 214-222
Authors:
Wagenknecht, B
Hermisson, M
Groscurth, P
Liston, P
Krammer, PH
Weller, M
Citation: B. Wagenknecht et al., Proteasome inhibitor-induced apoptosis of glioma cells involves the processing of multiple caspases and cytochrome c release, J NEUROCHEM, 75(6), 2000, pp. 2288-2297
Authors:
Wagenknecht, B
Glaser, T
Naumann, U
Kugler, S
Isenmann, S
Bahr, M
Korneluk, R
Liston, P
Weller, M
Citation: B. Wagenknecht et al., Expression and biological activity of X-linked inhibitor of apoptosis (XIAP) in human malignant glioma, CELL DEAT D, 6(4), 1999, pp. 370-376
Authors:
Wagenknecht, B
Hermisson, M
Eitel, K
Weller, M
Citation: B. Wagenknecht et al., Proteasome inhibitors induce p53/p21-independent apoptosis in human gliomacells, CELL PHYS B, 9(3), 1999, pp. 117-125
Authors:
Pohl, U
Wagenknecht, B
Naumann, U
Weller, M
Citation: U. Pohl et al., p53 enhances BAK and CD95 expression in human malignant glioma cells but does not enhance CD95L-induced apoptosis, CELL PHYS B, 9(1), 1999, pp. 29-37
Authors:
Glaser, T
Wagenknecht, B
Groscurth, P
Krammer, PH
Weller, M
Citation: T. Glaser et al., Death ligand/receptor-independent caspase activation mediates drug-inducedcytotoxic cell death in human malignant glioma cells, ONCOGENE, 18(36), 1999, pp. 5044-5053
Authors:
Eitel, K
Wagenknecht, B
Weller, M
Citation: K. Eitel et al., Inhibition of drug-induced DNA fragmentation, but not cell death, of glioma cells by non-caspase protease inhibitors, CANCER LETT, 142(1), 1999, pp. 11-16
Authors:
Wick, W
Grimmel, C
Wagenknecht, B
Dichgans, J
Weller, M
Citation: W. Wick et al., Betulinic acid-induced apoptosis in glioma cells: A sequential requirementfor new protein synthesis, formation of reactive oxygen species, and caspase processing, J PHARM EXP, 289(3), 1999, pp. 1306-1312
Risultati:
1-14
|